Obesity is present in over 90% of adolescents and the majority of adults with type 2 diabetes, whereas only 25% of patients with type 1 diabetes are overweight. 4 Approximately 30% of patients with type 2 diabetes have hypertension at presentation, 5 but it is rare at presentation in patients with type 1 diabetes.
C-peptide concentrations are usually high in patients with type 2 diabetes; hyperglycemia can cause transient insulin deficiency ("glucose toxicity") and a low initial plasma insulin level. In patients with type 1 diabetes, the decline in insulin level is steady over time. 6 Our patient maintained unexplainable normal to high C-peptide levels 38 years after diagnosis of type 1 diabetes. No sufficient data were found in the literature that explained the persistence of insulin secretion for such a long period.
Antibodies are present in 75 to 90% of patients with type 1 diabetes at presentation. 7 Adults who are thought to have type 2 diabetes and who have positive antibody tests eventually become insulin-dependent and are considered to have latent autoimmune diabetes. 8 In the absence of reliable diagnostic markers greater emphasis must be placed on the findings in the individual patient. This case demonstrated some type 2 features in a patient with type 1 diabetes. In daily practice, diagnoses often are generalized. Accurate diagnosis is important because the treatment and complications of type 1 and type 2 diabetes are distinct. Unfortunately, some cases of diabetes clearly cannot fit under a specific diagnosis.
The ultimate goal of treatment for type 2 diabetes is correction of the underlying insulin resistance through weight reduction, exercise, and medications. Patients with type 1 disease are at risk for other autoimmune disorders, such as thyroid, celiac, and Addison's disease. Whereas, patients with type 2 disease are at risk for hypertension, dyslipidemias, and macrovascular disease. The genetic implications for other family members also differ for the two disorders.
Conclusion
Proper diagnosis of type 1 and type 2 diabetes mellitus is crucial to the treatment that an affected patient is likely to receive. Type 1 and type 2 diabetes are two different entities although they may overlap. Some patients manifest features of both types at the same time. In the absence of specific markers between the two types, further evaluation with C-peptide levels and auto immune markers are appropriate to evaluate many adults with diabetes mellitus.
